Press Release

CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE

Jul 18, 2023

Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to Read More

CSRXP: PROPOSAL TO LOOSEN PATENT RULES WOULD FURTHER EMPOWER BIG PHARMA TO BLOCK COMPETITION

Jun 23, 2023

Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable, Read More

CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

May 11, 2023

U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and Read More

CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE

May 4, 2023

Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer Read More

CSRXP APPLAUDS REINTRODUCTION OF FAIR DRUG PRICING ACT

Mar 24, 2023

Bipartisan Transparency Legislation Will Help Hold Big Pharma Accountable for Read More

CSRXP: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE FOR UNCONSCIONABLE PRICE HIKES ON COVID-19 VACCINES AND TREATMENTS

Mar 22, 2023

Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to Read More

CSRXP STATEMENT ON ELI LILLY ANNOUNCEMENT ON PRICE OF INSULIN PRODUCTS

Mar 1, 2023

More Big Pharma Companies Should Also Lower Their Insulin Prices Read More

CSRXP APPLAUDS SENATORS FOR BIPARTISAN ACTION TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PATENT ABUSE

Feb 9, 2023

Senate Judiciary Committee Advances Critical Legislation to Crack Down on Read More

CSRXP APPLAUDS POSITIVE PROGRESS, ENCOURAGES POLICYMAKERS TO ADVANCE ADDITIONAL MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

Feb 8, 2023

Policies Must Address Big Pharma’s Egregious Practices That Cause High Drug Read More